Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosis-Reference-Cited by-同舟云学术

Impact of first-line immunotherapy on survival and intracranial outcomes in a cohort of non-small cell lung cancer patients with brain metastases at diagnosis

Published:2023-10 Issue: Volume:184 Page:107321
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Nigen Benoit,Goronflot Thomas,Herbreteau Guillaume,Mathiot Laurent,Sagan Christine,Raimbourg Judith,Bennouna Jaafar,Thillays François,Pons-Tostivint Elvire^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference41 articles.

1. Brain metastases;Achrol;Nat. Rev. Dis. Primers,2019

2. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study;Cagney;Neuro Oncol.,2017

3. Non-small-cell Lung Cancer With Brain Metastasis at Presentation;Waqar;Clin. Lung Cancer,2018

4. Targeted Therapy in Brain Metastases: Ready for Primetime?;Venur;Am. Soc. Clin. Oncol. Educ. Book,2016

5. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Planchard;Ann. Oncol.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer;Radiotherapy and Oncology;2024-09

2. CBNPC sans addictions oncogéniques métastatique cérébral d’emblée : place de l’immunothérapie;Revue des Maladies Respiratoires;2024-06

3. Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC;Frontiers in Oncology;2024-05-10

4. First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study;Frontiers in Oncology;2024-02-07

5. External Validation of the Lung-MolGPA to Predict Survival in Patients Treated with Stereotactic Radiotherapy for Brain Metastases of Non-Small Cell Lung Cancer;2024